
According to the South Korean team, doctors in China are interested in a partnership and learning more about an experimental drug that it has developed to combat the disease.
The team’s study, titled “Oxidative stress-induced astrocytic collagen biosynthesis drives glial barrier formation and neuronal death in ischemic stroke,” was published online last week in the journal Cell Metabolism.
Advertisement
Ischemic stroke occurs when a blood clot or other blockage obstructs a cerebral blood vessel, cutting off oxygen and nutrients and causing brain cells to die.
Advertisement
Survivors often suffer severe aftereffects, including motor disabilities and cognitive decline. Treatment is further complicated by a narrow three-hour “golden time” window after symptom onset, during which patients must receive emergency care.

Don't Miss:
-
China and US push Southeast Asia over their AI blocs. Will it test region’s non-alignment?
-
Man armed with sword injures several at Swedish high school
-
Ex-care home worker accused of raping intellectually disabled woman 5 times
-
Tesla forced to recall record 3 million cars in China over door-handle issue
-
OpenAI-backed legal tech firm pivots to Chinese Kimi K3 open-weight model

After Years of Waiting, Noel Tata Presides Unchallenged over India’s Biggest Business
Despite years of confiscations, the Met still holds hundreds of pieces linked to alleged trafficking and looting figures
Ex-Evergrande Boss Hui Ka Yan gets Life in Prison